The infectious diseases clinical research program acute respiratory infection repository protocol: Opportunities to understand current and future epidemics.
<h4>Background</h4>Acute respiratory infections (ARI) are a major cause of morbidity and lost workdays in both military and non-military populations. To better understand these infections and their outcomes, the Infectious Diseases Clinical Research Program has enabled nine major ARI cli...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0317065 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849687263049416704 |
|---|---|
| author | Simon D Pollett Rhonda E Colombo Stephanie A Richard Tahaniyat Lalani Brianne Barton Allison Malloy Anthony Fries Edward Parmelee Scott Merritt Mark Fritschlanski Edward E Mitre Eric D Laing Kathleen Pratt Eric C Garges Katrin Mende Mark Simons Brian Agan David Tribble Robert O'Connell Timothy H Burgess |
| author_facet | Simon D Pollett Rhonda E Colombo Stephanie A Richard Tahaniyat Lalani Brianne Barton Allison Malloy Anthony Fries Edward Parmelee Scott Merritt Mark Fritschlanski Edward E Mitre Eric D Laing Kathleen Pratt Eric C Garges Katrin Mende Mark Simons Brian Agan David Tribble Robert O'Connell Timothy H Burgess |
| author_sort | Simon D Pollett |
| collection | DOAJ |
| description | <h4>Background</h4>Acute respiratory infections (ARI) are a major cause of morbidity and lost workdays in both military and non-military populations. To better understand these infections and their outcomes, the Infectious Diseases Clinical Research Program has enabled nine major ARI clinical research protocols in the last decade, including observational studies and trials, spanning emerging and reemerging ARI threats including Severe Acute Respiratory Syndrome Coronavirus 2, influenza, adenovirus, entero/rhinovirus, human metapneumovirus, respiratory syncytial virus, and other pathogens. These protocols have resulted in epidemiological, clinical and laboratory data and biospecimens from over 26,000 participants, most of whom were beneficiaries of a geographically distributed Military Health System.<h4>Methods</h4>The Acute Respiratory Infection Repository Protocol establishes a unique Department of Defense (DoD) research resource through the pooling of data and specimens from nine ARI protocols into a master, standardized database with a linked specimen repository. This will enable further targeted scientific questions in participant-level pooled meta-analyses and will serve as an on-demand repository for rapid assay development, sample size estimations for prospective studies, and observational study/clinical trial design (including as part of future rapid pandemic research response). Accordingly, the objectives and study design of this protocol are broad. This protocol will allow analyses on outcomes including: (i) short-term ARI outcomes such as hospitalization, work days lost, symptom severity and duration; (ii) post-acute ARI outcomes, including persistence of symptoms, return-to-health, post-ARI medical encounters; (iii) vaccine effectiveness for Coronavirus disease 2019 (COVID-19), influenza, and adenovirus vaccines; (iv) ARI infection and vaccination elicited immune responses (humoral, T-cell, other); (v) therapeutic effectiveness of COVID-19 and influenza antivirals (acute symptoms, hospitalization, post-acute sequelae); (vi) effectiveness of non-pharmaceutical interventions (e.g., masking) against infection; (vii) prognostic and mechanistic host viral biomarkers which correlate with the above outcomes; (viii) ARI diagnostic assay validity and performance. This repository protocol is inherently broad in scope; the collation of standardized data and phenotype-linked specimens is a fundamental, primary objective.<h4>Discussion</h4>This protocol will support statistical and laboratory analyses, including activities related to rapid epidemic response such as assay development and rapid sample size calculations for clinical trials. A series of more specific scientific questions from current and future collaborators will leverage this joint database and specimen repository; these questions will target important aspects of ARI infection, transmission, outcomes, and treatment. Future protocols (and ongoing data from existing IDCRP protocols) will be added to this collaborative repository protocol. |
| format | Article |
| id | doaj-art-8a4be342c98d4e769e2081e4fbd0f7fa |
| institution | DOAJ |
| issn | 1932-6203 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-8a4be342c98d4e769e2081e4fbd0f7fa2025-08-20T03:22:22ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01207e031706510.1371/journal.pone.0317065The infectious diseases clinical research program acute respiratory infection repository protocol: Opportunities to understand current and future epidemics.Simon D PollettRhonda E ColomboStephanie A RichardTahaniyat LalaniBrianne BartonAllison MalloyAnthony FriesEdward ParmeleeScott MerrittMark FritschlanskiEdward E MitreEric D LaingKathleen PrattEric C GargesKatrin MendeMark SimonsBrian AganDavid TribbleRobert O'ConnellTimothy H Burgess<h4>Background</h4>Acute respiratory infections (ARI) are a major cause of morbidity and lost workdays in both military and non-military populations. To better understand these infections and their outcomes, the Infectious Diseases Clinical Research Program has enabled nine major ARI clinical research protocols in the last decade, including observational studies and trials, spanning emerging and reemerging ARI threats including Severe Acute Respiratory Syndrome Coronavirus 2, influenza, adenovirus, entero/rhinovirus, human metapneumovirus, respiratory syncytial virus, and other pathogens. These protocols have resulted in epidemiological, clinical and laboratory data and biospecimens from over 26,000 participants, most of whom were beneficiaries of a geographically distributed Military Health System.<h4>Methods</h4>The Acute Respiratory Infection Repository Protocol establishes a unique Department of Defense (DoD) research resource through the pooling of data and specimens from nine ARI protocols into a master, standardized database with a linked specimen repository. This will enable further targeted scientific questions in participant-level pooled meta-analyses and will serve as an on-demand repository for rapid assay development, sample size estimations for prospective studies, and observational study/clinical trial design (including as part of future rapid pandemic research response). Accordingly, the objectives and study design of this protocol are broad. This protocol will allow analyses on outcomes including: (i) short-term ARI outcomes such as hospitalization, work days lost, symptom severity and duration; (ii) post-acute ARI outcomes, including persistence of symptoms, return-to-health, post-ARI medical encounters; (iii) vaccine effectiveness for Coronavirus disease 2019 (COVID-19), influenza, and adenovirus vaccines; (iv) ARI infection and vaccination elicited immune responses (humoral, T-cell, other); (v) therapeutic effectiveness of COVID-19 and influenza antivirals (acute symptoms, hospitalization, post-acute sequelae); (vi) effectiveness of non-pharmaceutical interventions (e.g., masking) against infection; (vii) prognostic and mechanistic host viral biomarkers which correlate with the above outcomes; (viii) ARI diagnostic assay validity and performance. This repository protocol is inherently broad in scope; the collation of standardized data and phenotype-linked specimens is a fundamental, primary objective.<h4>Discussion</h4>This protocol will support statistical and laboratory analyses, including activities related to rapid epidemic response such as assay development and rapid sample size calculations for clinical trials. A series of more specific scientific questions from current and future collaborators will leverage this joint database and specimen repository; these questions will target important aspects of ARI infection, transmission, outcomes, and treatment. Future protocols (and ongoing data from existing IDCRP protocols) will be added to this collaborative repository protocol.https://doi.org/10.1371/journal.pone.0317065 |
| spellingShingle | Simon D Pollett Rhonda E Colombo Stephanie A Richard Tahaniyat Lalani Brianne Barton Allison Malloy Anthony Fries Edward Parmelee Scott Merritt Mark Fritschlanski Edward E Mitre Eric D Laing Kathleen Pratt Eric C Garges Katrin Mende Mark Simons Brian Agan David Tribble Robert O'Connell Timothy H Burgess The infectious diseases clinical research program acute respiratory infection repository protocol: Opportunities to understand current and future epidemics. PLoS ONE |
| title | The infectious diseases clinical research program acute respiratory infection repository protocol: Opportunities to understand current and future epidemics. |
| title_full | The infectious diseases clinical research program acute respiratory infection repository protocol: Opportunities to understand current and future epidemics. |
| title_fullStr | The infectious diseases clinical research program acute respiratory infection repository protocol: Opportunities to understand current and future epidemics. |
| title_full_unstemmed | The infectious diseases clinical research program acute respiratory infection repository protocol: Opportunities to understand current and future epidemics. |
| title_short | The infectious diseases clinical research program acute respiratory infection repository protocol: Opportunities to understand current and future epidemics. |
| title_sort | infectious diseases clinical research program acute respiratory infection repository protocol opportunities to understand current and future epidemics |
| url | https://doi.org/10.1371/journal.pone.0317065 |
| work_keys_str_mv | AT simondpollett theinfectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT rhondaecolombo theinfectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT stephaniearichard theinfectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT tahaniyatlalani theinfectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT briannebarton theinfectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT allisonmalloy theinfectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT anthonyfries theinfectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT edwardparmelee theinfectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT scottmerritt theinfectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT markfritschlanski theinfectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT edwardemitre theinfectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT ericdlaing theinfectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT kathleenpratt theinfectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT ericcgarges theinfectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT katrinmende theinfectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT marksimons theinfectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT brianagan theinfectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT davidtribble theinfectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT robertoconnell theinfectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT timothyhburgess theinfectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT simondpollett infectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT rhondaecolombo infectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT stephaniearichard infectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT tahaniyatlalani infectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT briannebarton infectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT allisonmalloy infectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT anthonyfries infectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT edwardparmelee infectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT scottmerritt infectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT markfritschlanski infectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT edwardemitre infectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT ericdlaing infectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT kathleenpratt infectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT ericcgarges infectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT katrinmende infectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT marksimons infectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT brianagan infectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT davidtribble infectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT robertoconnell infectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics AT timothyhburgess infectiousdiseasesclinicalresearchprogramacuterespiratoryinfectionrepositoryprotocolopportunitiestounderstandcurrentandfutureepidemics |